NICE
NICE Ltd.
NICE has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over NICE overall, supported by stronger fundamentals and stronger modeled upside.
NICE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
NICE's revenue, profitability, cash flow and balance sheet are all currently healthy.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
NICE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $94.12 | — |
| Cheap | 17x | $116 | +23% |
| Fair | 49x | $341 | +263% |
| Expensive | 76x | $522 | +454% |
Historical ranges are pointers, not guarantees.
NICE's PE is in its cheap range at 14x.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over NICE in the historical PE scenario, which offers more potential upside but is not a forecast.
NICE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NICE, with profitability holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over NICE on the outlook, with more favorable profitability expectations.
NICE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $6.90 | -18% |
| Q1 2026 | $8.43 | +18% |
| Q4 2025 | $9.67 | +43% |
| Q3 2025 | $8.80 | +36% |
| Q2 2025 | $8.37 | +40% |
| Q1 2025 | $7.17 | +29% |
| Q4 2024 | $6.76 | +33% |
| Q3 2024 | $6.46 | +31% |
NICE earned $6.90 per share over the past year, down 18% from the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over NICE in the latest year-over-year earnings comparison.
NICE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $795.7M | +9.5% |
| Q1 2026 | $766.5M | +9.5% |
| Q4 2025 | $786.5M | +9% |
| Q3 2025 | $732M | +6.1% |
| Q2 2025 | $726.7M | +9.4% |
| Q1 2025 | $700.2M | +6.2% |
| Q4 2024 | $721.6M | +16% |
| Q3 2024 | $690M | +15% |
NICE's revenue has grown year over year every quarter since late 2020: $796M last quarter, up 9.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | -8.3 points |
| Q1 2026 | 16% | -4.7 points |
| Q4 2025 | 22% | +1 points |
| Q3 2025 | 22% | +1.5 points |
| Q2 2025 | 22% | +2.7 points |
| Q1 2025 | 21% | +2.7 points |
| Q4 2024 | 21% | +1.7 points |
| Q3 2024 | 20% | +1.6 points |
NICE's operating margin was 14% last quarter, down 8.3 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over NICE on profitability, with a higher operating margin.
NICE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $117.3M | +204% |
| Q1 2026 | $169.4M | -36% |
| Q4 2025 | $156M | -31% |
| Q3 2025 | $163.6M | +24% |
| Q2 2025 | $38.6M | -74% |
| Q1 2025 | $264.6M | +16% |
| Q4 2024 | $225.1M | +40% |
| Q3 2024 | $131.7M | +28% |
NICE generated $606M in free cash flow over the past year, down 8.2% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over NICE on cash flow, with more consistent year-over-year improvement.
NICE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -1.2M shares |
| 1 year | -6% | -3.8M shares |
| 3 years | -11% | -7M shares |
| 5 years | -11% | -7.1M shares |
| Available history | -8.7% | -5.7M shares |
NICE has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $60.8M |
| Q1 2026 | $252.6M |
| Q4 2025 | $165.2M |
| Q3 2025 | $40.6M |
| Q2 2025 | $30.8M |
| Q1 2025 | $252.3M |
| Q4 2024 | $95.2M |
| Q3 2024 | $86.4M |
NICE spent $519M buying back its own shares over the past year, up 12% from the year before.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
NICE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | 0.0x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.1x | Net Cash |
NICE has more cash than debt.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
NICE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 24.3 | Neutral |
NICE's weekly RSI is 43 (neutral) and its Stochastic is 24 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
NICE PE vs Technology Sector
| Metric | NICE | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 51% below |
| PE % | 13 | 35 | 22 pts below |
NICE is trading at 14x earnings, a 51% discount to the Technology sector's median of 28x.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over NICE on valuation relative to its sector.
NICE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $110.2 | 15% below |
| 20 week MA | $104.5 | 9.9% below |
| 50 week MA | $105.3 | 11% below |
| 100 week MA | $128.5 | 27% below |
| 200 week MA | $162.8 | 42% below |
SNDK has stronger trend alignment. NICE is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
NICE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $156.3 | $279.8 | +79% |
| 2021 | $279.8 | $306.4 | +9.5% |
| 2022 | $306.4 | $194.7 | -36% |
| 2023 | $194.7 | $199.5 | +2.5% |
| 2024 | $199.5 | $173.5 | -13% |
| 2025 | $173.5 | $112.7 | -35% |
| 2026 YTD | $112.7 | $94.1 | -16% |
NICE has finished lower in three of the last six years. It's down 16% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over NICE on returns for 2026, with the stronger performance.